BEOVU in the Treatment of Dystrophy-related Macular Neovascular Degeneration
NCT04690062
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Dystrophy, Retinal
Interventions
DRUG:
Brolucizumab-Dbll
Sponsor
Benha University